No Data
No Data
Why You Might Be Interested In ZhuZhou QianJin Pharmaceutical Co.,Ltd (SHSE:600479) For Its Upcoming Dividend
Zhuzhou Qianjin Pharmaceutical (600479.SH) 2023 equity distribution: 0.35 yuan per share.
Zhuzhou Qianjin Pharmaceutical (600479.SH) announced that the annual equity distribution for 2023 will be implemented according to the plan...
Qianjin Pharmaceutical (600479.SH): Recent torrential rain and hail have not affected the company's herbal medicine planting base
Gelonghui, May 30丨Qianjin Pharmaceutical (600479.SH) said on the investor interactive platform that the recent torrential rain and hail had no impact on our herbal medicine planting base.
Qianjin Pharmaceutical (600479.SH) Strategic Plan: Strive to reach 8 billion yuan in revenue by the end of 2031
Gelonghui May 20 丨 Qianjin Pharmaceutical (600479.SH) announced the strategic plan outline (2024-2031), aiming to reach 8 billion yuan in revenue by the end of 2031, of which the pharmaceutical industry's revenue reached 5 billion yuan, and the net profit margin was not lower than the average of the pharmaceutical industry. From a leading pharmaceutical enterprise in Hunan Province to the top 100 pharmaceutical industry in the country, it has become the most influential benchmark enterprise in the field of women's health in China.
Qianjin Pharmaceutical (600479.SH) announced first-quarter results, net profit of 46.188 million yuan, up 5.22% year-on-year
According to Zhitong Finance App News, Qianjin Pharmaceutical (600479.SH) released its report for the first quarter of 2024. During the reporting period, the company achieved operating income of 1,001 billion yuan, an increase of 4.22%; net profit attributable to shareholders of listed companies was 46.188 million yuan, an increase of 5.22% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 43.5086 million yuan, an increase of 21.25% year on year; basic earnings per share were 0.1,077 yuan.
Qianjin Pharmaceutical (600479.SH): Net profit increased 5.92% year-on-year in 2023, and plans to split 10 to 3.5 yuan
On April 11, Ge Longhui (600479.SH) released its 2023 annual report. During the reporting period, it achieved operating income of 3,798 billion yuan, a year-on-year decrease of 5.66%; net profit attributable to shareholders of listed companies was 320 million yuan, up 5.92% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 304 million yuan, up 8.94% year on year; and basic earnings per share were 0.7583 yuan. It is proposed to pay a cash dividend of 3.5 yuan (tax included) for every 10 shares to all shareholders of the company.
No Data